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Summary
 
It is well established that apoptosis is accompanied by activation of procaspases and by mito-
chondrial changes, such as decrease in mitochondrial transmembrane potential (
 
DC
 
m
 
) and re-
lease of cytochrome c. We analyzed the causal relationship between activated caspases and these
mitochondrial phenomena. Purified recombinant caspase-1, -11, -3, -6, -7, and -8 were incu-
bated with mitochondria in the presence or absence of additional cellular components, after
which 
 
DC
 
m
 
 was determined. At lower caspase concentrations, only caspase-8 was able to acti-
vate a cytosolic factor, termed caspase-activated factor (CAF), which resulted in decrease in
 
DC
 
m
 
 and release of cytochrome c. Both CAF-mediated activities could not be blocked by pro-
tease inhibitors, including oligopeptide caspase inhibitors. CAF-induced cytochrome c release,
but not decrease of 
 
DC
 
m
 
, was blocked in mitochondria from cells overexpressing Bcl-2. CAF is
apparently involved in decrease of 
 
DC
 
m
 
 and release of cytochrome c, whereas Bcl-2 only pre-
vents the latter. Hence, CAF may form the link between death domain receptor–dependent
activation of procaspase-8 and the mitochondrial events studied.
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A
 
family of cysteine proteases, termed caspases, plays a
central part in both induction and execution of apop-
tosis mediated by Fas and the p55 TNF receptor. Caspases
are expressed as inactive zymogens and become activated
by autoproteolytic processing (1) or cleavage by other
caspases (2) at specific aspartic acid residues. After activa-
tion, caspases cleave their substrates, e.g., caspase zy-
mogens, as well as cytosolic, nuclear, and cytoskeletal pro-
teins (3). For several caspases, participation in cell death,
especially in Fas-induced apoptosis, has been established
(4). After aggregation of Fas and subsequent formation of
the death-inducing signaling complex (DISC), recruitment
of procaspase-8 to DISC is followed by autoproteolytic ac-
tivation of this caspase (5, 6). Depending on the amount of
active caspase-8 generated at the receptor complex, two
types of Fas-induced apoptosis have been described (7). In
type I cells, recruitment of high amounts of procaspase-8
results in direct activation of executioner caspases accompa-
nied by loss of mitochondrial transmembrane potential
(
 
DC
 
m
 
) and release of cytochrome c from the mitochondria.
In type II cells, where low amounts of procaspase-8 are re-
cruited to DISC, mitochondrial membrane depolarization
(MMD) and release of cytochrome c precede activation of
caspase-3. This release of cytochrome c may initiate the ex-
ecution phase (8) by Apaf-1–mediated processing of pro-
caspase-9 to active caspase-9, resulting in activation of
caspase-3 (9, 10). Accordingly, inhibition of MMD and cy-
tochrome c release by overexpression of the antiapoptotic
protein Bcl-2 blocks apoptosis in type II but not in type I
cells (7).
In addition, other triggers of apoptosis, such as overex-
pression of the proapoptotic protein Bax (11), accumulation
of the secondary messenger ceramide (12), treatment with
etoposide or staurosporine (13, 14), and exposure to ioniz-
ing radiation (14, 15), are dependent on or accompanied by
MMD and/or release of cytochrome c from the mitochon-
dria. Recently, activation of a cytochrome c efflux–induc-
ing factor (CIF) during staurosporine-induced apoptosis has
been demonstrated (16). However, the mechanism by
which death receptors induce MMD and the release of cyto-
chrome c remains elusive. In particular, the relative contri-
bution, if any, of the executioner caspases-3, -6, and -7,
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but also of the initiation caspases-1, -11, and -8, to the gen-
eration of these mitochondrial phenomena remains an in-
triguing question.
In this paper, we analyzed the efficacy of purified recom-
binant caspase-1, -3, -6, -7, -8, and -11 to induce MMD in
isolated mitochondria in the presence or absence of addi-
tional cellular components. We identified an intermediary
protein, termed caspase-activated factor (CAF), which gen-
erates MMD and cytochrome c release by a nonproteolytic
mechanism. Accordingly, CAF may constitute a crucial
link between the caspase cascade and these mitochondrial
events.
 
Materials and Methods
 
Cells.
 
Murine T cell hybridomas PC60R55R75,
PC60R55P75-Neo
 
r
 
, and PC60R55P75–Bcl-2 (17) were cul-
tured in RPMI 1640 supplemented with 10% FCS, 100 U/ml
penicillin, 0.1 mg/ml streptomycin, 2 mM 
 
l
 
-glutamine, 5 
 
3 
 
10
 
-5
 
 M
2-ME, and 1 mM sodium pyruvate.
 
Reagents and Caspases.
 
Carbonyl cyanide 
 
m
 
-chlorophenylhy-
drazone (mClCCP) and atractyloside were purchased from Sigma
Chemical Co. (St. Louis, MO). Rhodamine 123 (R123; Mol-
ecular Probes, Inc., Eugene, OR) was prepared as a 10 mM stock
solution in DMSO and was used at 0.1 
 
m
 
M. The caspase pep-
tide inhibitors benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp
(OMe)-fluoromethylketone (zDEVD-fmk) and benzyloxycarbo-
nyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk; both
from Enzyme Systems Products, Dublin, CA) as well as acetyl-
Tyr-Val-Ala-Asp-chloromethylketone (Ac-YVAD-cmk; Calbio-
chem-Novabiochem International, San Diego, CA) were pre-
pared as 100 mM stock solutions in DMSO and were used at 10
 
m
 
M. Purified recombinant murine caspases were prepared as de-
scribed (18).
 
Preparation of Cytosol Extract.
 
Cytosol was prepared by cen-
trifugation (100,000 
 
g
 
; 30 min) of PC60 cells (0.5 
 
3 
 
10
 
9
 
 cells/ml
in cell-free system buffer) permeabilized with 0.07% digitonin.
Cell-free system buffer comprised 220 mM mannitol, 68 mM su-
crose, 2 mM NaCl, 2 mM MgCl
 
2
 
, 2.5 mM PO
 
4
 
H
 
2
 
K, 0.5 mM
EGTA, 0.5 mM sodium pyruvate, 0.5 mM 
 
l
 
-glutamine, and 10 mM
Hepes-NaOH (pH 7.4), supplemented with 100 
 
m
 
M chymosta-
tin, 28 
 
m
 
M E-64, 1 
 
m
 
M leupeptin, 1 
 
m
 
M pepstatin, and 0.3 
 
m
 
M
aprotinin.
 
Preparation of Organelles.
 
10 
 
3 
 
10
 
6
 
 PC60 cells were permeabi-
lized with 0.01% digitonin in 2 ml of isolation buffer, pH 7.4,
comprising 220 mM mannitol, 68 mM sucrose, 2.5 mM
PO
 
4
 
H
 
2
 
K, 1 mM EGTA, 10 mM Hepes-NaOH, and 0.5% BSA.
Mitochondria were isolated by differential centrifugation. After
homogenization, cell debris and supernatant were removed by
centrifugation (20 s at 10,000 
 
g
 
 and 10 min at 15,000 
 
g
 
, respec-
tively) to pellet down the mitochondria. The latter were resus-
pended in isolation buffer and stored on ice for up to 1 h. All
steps were carried out at 4
 
8
 
C.
 
Determination of MMD.
 
Serial caspase dilutions were obtained
in cell-free system buffer, supplemented with 5 mM dithiothrei-
tol and 2 mM ADP. 10
 
5
 
 permeabilized PC60 cells or isolated
mitochondria from 10
 
5
 
 PC60 cells were incubated with caspases
for 30 min at 37
 
8
 
C. MMD was detected by flow-cytometric anal-
ysis of R123 accumulation (FACScalibur
 
Ò
 
; Becton Dickinson,
Mountain View, CA [19]). R123 was excited with a 488-nm
argon ion laser; fluorescence emission was measured at 525 nm.
 
Determination of Cytochrome c Release.
 
10
 
6
 
 digitonin-permeabi-
lized  PC60 cells or isolated mitochondria from 10
 
6
 
 PC60 cells
were incubated in cell-free system buffer, with or without
caspase-8 or in caspase-8–activated or untreated cytosol extract,
both supplemented with 5 mM dithiothreitol and 2 mM ADP at
37
 
8
 
C for 30 min. Opened cells or mitochondria were pelleted by
centrifugation (15,000 
 
g
 
 for 5 min). Supernatant was analyzed by
15% SDS-PAGE, using mAB to cytochrome c (PharMingen, San
Diego, CA) and ECL-based detection (Nycomed Amersham plc,
Little Chalfont, Bucks, UK).
 
Fluorogenic Substrate Assay for Caspase Activity.
 
Caspase-3–like ac-
tivity was determined by incubation of cytosol extracts (containing
25 
 
m
 
g total protein) with 50 
 
m
 
M of the fluorogenic substrate
acetyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-aminomethylcou-
marin (Ac-DEVD-amc; Peptide Institute, Osaka, Japan) in 200 
 
m
 
l
cell-free system buffer. The release of fluorescent 7-amino-4-methyl-
coumarin was measured for 20 min at 2-min intervals by spectro-
fluorometry (CytoFluor 2300; PerSeptive Biosystems, Cambridge,
MA) at 480 nm, using an excitation wavelength of 360 nm.
 
Results and Discussion
 
Caspase-8 Induces MMD in Cooperation with an Additional
Cellular Factor.
 
It was recently reported that caspase-1,
-2, -3, -4, and -6 induce MMD in intact mitochondria
(20). However, to obtain the MMD-inducing effect, high
amounts of caspase activity were used. To verify whether
additional cellular components promote the MMD-induc-
ing activity at low caspase concentrations, we quantified
the MMD-inducing capacity of serial dilutions from mu-
rine caspase-1, -11, -3, -6, -7, and -8 on isolated PC60 mi-
tochondria and on mitochondria in permeabilized PC60
cells. Cells had been permeabilized with digitonin, a mild
detergent which, at low concentration, dissolves plasma
membranes without harming mitochondrial membranes
(21). This open cell system allows the introduction of
membrane-impermeable proteins while preserving the in-
tegrity of mitochondria and maintaining the presence of
cytosolic components. MMD was determined by flow-
cytometric analysis of 
 
DC
 
m
 
 using the mitochondria-specific
and potential-sensitive dye, R123 (19). Induction of MMD
by uncoupling of the respiratory chain with the protono-
phore mClCCP or by atractyloside, an inhibitory ligand of
the adenine nucleotide translocator which induces MMD
by opening the permeability transition pores (22), resulted
in a 10-fold drop in R123 fluorescence intensity both in
isolated mitochondria and opened cell mitochondria (Fig.
1, 
 
inset
 
). This shows that the two types of mitochondria
display similar functionality and that both in vitro systems
are suited for MMD analysis.
The critical concentration needed to induce MMD was
determined for each caspase. In isolated PC60 mitochon-
dria (Fig. 1), caspase-6 and -8 were highly inefficient and
generated MMD at a concentration of 60 
 
m
 
g/ml only.
Caspase-1 and -3 were slightly more efficient, exhibiting a
critical concentration of 30 
 
m
 
g/ml. Caspase-11 and -7
scored best, with critical concentrations of 15 and 8 
 
m
 
g/ml,
respectively. These results are in agreement with previous
reports demonstrating that caspases induce MMD in intact 
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mitochondria (20), and further substantiate the low efficacy
at which caspases, especially caspase-6 and -8, generate this
response.
In contrast to the low efficacy in isolated mitochondria,
all caspases showed a higher MMD-inducing activity in
opened cell mitochondria (Fig. 1), the critical concentra-
tion decreasing twofold for caspase-1 and -7, fourfold for
caspase-11 and -6, or eightfold for caspase-3. However,
caspase-8 exhibited the most drastic shift, evolving from
nearly no activity on isolated mitochondria to the most ef-
ficient activity in opened cells, with a critical concentration
of 0.5 
 
m
 
g/ml. These results indicate that the caspases assayed
induce, in intact cells, MMD mainly or exclusively (caspase-
8) by cooperation with an intermediate cellular compo-
nent(s), rather than by a direct mechanism. Since caspase-8
is the most effective caspase for inducing MMD in perme-
abilized cells and also the most apical caspase activated in the
Fas-induced signal transduction pathway to cell death (5, 6),
such cooperative activity may combine recruitment to
DISC of procaspase-8 and occurrence of MMD.
 
Caspase-8 Activates a Cytosolic Protein that Induces MMD in
Isolated Mitochondria by a Nonproteolytic Mechanism.
 
To re-
constitute the cytosolic signaling cascade to the mitochon-
dria, cytosol extracts of digitonin-permeabilized PC60 cells
were applied to isolated PC60 mitochondria. Without ad-
ditional treatment, these cytosol extracts had no effect on
 
DC
 
m
 
 (Fig. 2). However, the addition of caspase-8 enabled
the induction of MMD. The minimal caspase-8 concentra-
tion required to activate the cytosol extract was 0.5 
 
m
 
g/ml,
at which concentration caspase-8 cannot induce MMD in
isolated mitochondria. This substantiates the necessity of a
cooperative cytosolic factor in order to obtain induction of
MMD by caspase-8 in isolated mitochondria. The new fac-
tor is a protein, since the caspase-8–activated extract re-
tained its MMD-inducing activity after dialysis, but became
inactive after heat treatment (data not shown).
We also verified whether caspase-8 or secondary acti-
vated caspases in the cytosol extract are responsible for in-
ducing MMD or, alternatively, whether MMD is induced
by a secondary noncaspase effector molecule. To that end,
Figure 1. Critical caspase concentration for induction of MMD in isolated mitochondria and opened cell mitochondria. Serial dilutions of six purified
recombinant caspases were analyzed for their ability to induce MMD in isolated PC60 mitochondria (left panels of each column) and digitonin-permeabi-
lized PC60 cells (right panels of each column) after 30-min incubation at 378C. DCm was measured using 0.1 mM R123 and flow cytometry. For each
caspase, only the R123 fluorescence histograms from mitochondria treated with a caspase concentration just above and below the critical concentration to
induce MMD are shown. Caspases are arranged according to their critical concentration for MMD induction in opened cell mitochondria and isolated
mitochondria. Inset, analysis of MMD due to uncoupling of the respiratory chain by 50 mM mClCCP and to induction of permeability transition by 5
mM atractyloside after 30-min incubation at 378C. 
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all caspase activity in the caspase-8–treated cytosol extract
was blocked with 10 
 
m
 
M of the broad-spectrum caspase in-
hibitor zVAD-fmk. Although this resulted in complete loss
of caspase activity (Fig. 2, 
 
inset
 
), the MMD-inducing activ-
ity of the treated extract remained unaffected (Fig. 2). In
addition, Ac-YVAD-cmk and zDEVD-fmk, which at 10 
 
m
 
M
are specific inhibitors of the caspase-1 and -3 subfamilies,
respectively, did not block the MMD-inducing activity in
the caspase-8–activated extract (data not shown). In the cy-
tosol extract of permeabilized PC60 cells, caspase-8 appar-
ently activates an MMD-inducing activity that does not de-
pend on caspase activity. This suggests the existence of an
additional effector protein, which induces MMD in iso-
lated mitochondria. Because the protein is activated by
caspase treatment, we termed it CAF.
Treatment of caspase-8 with zVAD-fmk rendered cas-
pase-8 unable to generate CAF (data not shown). Thus,
generation of CAF requires caspase-8 proteolytic activity,
so CAF may be part of a proteolytic cascade. Accordingly,
we verified whether the MMD-inducing activity of CAF
itself is exerted by a proteolytic or nonproteolytic mecha-
nism. However, protease inhibitors specific for different
protease families did not affect the ability of caspase-8–
treated cytosol extracts to induce MMD in isolated mito-
chondria (Table 1). These results show the existence of a
caspase-activated protein, CAF, which possibly connects
procaspase-8 recruitment and activation by death receptor
aggregation with the occurrence of MMD.
 
CAF Induces Cytochrome c Release from Isolated Mitochon-
dria.
 
The major proapoptotic activity of mitochondria is
the release of cytochrome c from the mitochondrial inter-
membrane space (11–15), resulting in activation of down-
stream caspase-3 (9, 10). We show that caspase-8–activated
and zVAD-fmk–treated cytosol extract (CAF) induces cy-
tochrome c release from isolated PC60 mitochondria (Fig.
3). Untreated cytosol extracts or caspase-8 by itself were
unable to induce cytochrome c release. This indicates that
CAF, by releasing cytochrome c from the mitochondria,
may contribute to activation of caspase-3 and to execution
of the apoptotic program.
 
Bcl-2 Prevents CAF-induced Cytochrome c Release, But Not
MMD in Vitro.
 
It was shown in various models of apop-
tosis that overexpression of Bcl-2 prevents MMD and cyto-
chrome c release (7, 13, 14). Using permeabilized PC60
cells overexpressing Bcl-2 as a result of gene transfection
(17), we analyzed the effect of Bcl-2 on CAF-induced
MMD and cytochrome c release. Mitochondria in opened
neomycin-resistant control cells showed cytochrome c re-
lease after treatment with caspase-8–activated and zVAD-
fmk–treated cytosol extract as well as MMD, confirming
that CAF entered the permeabilized cells. Addition of CAF
Figure 2. Caspase-8 induces MMD in isolated mitochondria by a cyto-
solic noncaspase intermediate. R123 fluorescence profiles of isolated
PC60 mitochondria after 30-min incubation at 378C with cell extract
prepared from digitonin-permeabilized PC60 cells pretreated for 20 min
with caspase-8 control buffer (A and E) and 1 mg/ml caspase-8 (B and D).
Respective cell extracts were postincubated with 10 mM zVAD-fmk for
15 min (C and D). Caspase activity in the corresponding cytosol extracts
was determined by accumulation of 7-amino-4-methylcoumarin fluores-
cence (Fl. I.), generated as a result of proteolytic modification of the fluo-
rogenic caspase-3 substrate Ac-DEVD-amc (inset).
 
Table 1.
 
Protease Inhibitors Do Not Block CAF-induced MMD
 
Inhibitor Specificity Inhibition of CAF
Antipain (74 
 
m
 
M) Papain, trypsin, cathepsin B None
Aprotinin (0.3 
 
m
 
M) Serine proteases None
Bestatin (130 
 
m
 
M) Metalloamino peptidases None
Chymostatin (100 
 
m
 
M)
 
a2
 
, 
 
b2
 
, 
 
g2
 
, 
 
d
 
-Chymotrypsin None
E-64 (28 
 
m
 
M) Cysteine proteases None
Leupeptin (1 
 
m
 
M) Serine and cysteine proteases None
Pepstatin (1 
 
m
 
M) Aspartate proteases None
Phosphoramidon (0.6 mM) Metalloproteases None
Caspase-8–activated PC60 cell extracts were treated with different protease inhibitors for 30 min at 20
 
°
 
C. CAF activity was determined on the basis
of CAF-induced MMD in isolated PC60 mitochondria. MMD was measured by flow-cytometric 
 
DC
 
m
 
 analysis. 
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to opened Bcl-2–overexpressing PC60 cells resulted in re-
lease of only marginal amounts of cytochrome c, whereas
MMD was induced to the same extent as in neomycin-
resistant control cells (Fig. 4). This shows that Bcl-2 primarily
blocks the CAF-induced release of cytochrome c, which is
the mitochondrial event crucial for execution of apoptosis,
while CAF-induced MMD remains unaffected.
 
Conclusion.
 
We provide compelling evidence for the
existence of a cytosolic protein, CAF, which is activated by
caspase-8 after proteolytic processing and which induces
MMD as well as proapoptotic mitochondrial function of
cytochrome c release by a nonproteolytic mechanism.
Since caspase-8 by itself only induces MMD at extremely
high (
 
.30 mg/ml), hence nonphysiological concentrations,
CAF is a possible component of the death receptor–
induced pathway to the mitochondria. Furthermore, CAF-
induced cytochrome c release was blocked by overexpres-
sion of Bcl-2, which meets the inhibitory activity of Bcl-2
on cytochrome c release and on MMD observed in several
models of apoptosis (7, 12–14). However, in contrast to
previous observations, overexpressed Bcl-2 did not prevent
CAF-induced MMD in opened cell mitochondria. This
might indicate that Bcl-2 prevents, by its effect on the mi-
tochondrial volume homeostasis (23), the rupture of the
mitochondrial outer membrane and thus the release of cy-
tochrome c, while its effect on the presumed opening of
the permeability transition pore and the resulting MMD
(22) remains limited. An alternative mechanism derives
from the observation that cytochrome c release precedes
MMD (13–15) or occurs in the absence of MMD (24). As a
consequence and despite the fact that both CAF-induced
mitochondrial events occurred almost simultaneously (data
not shown), cytochrome c release and MMD may repre-
sent two independent outcomes of the same CAF-induced
event differentially regulated by Bcl-2.
This research was supported by the Interuniversitaire Attractiepolen. M. Steemans and K. De Vos are fellows
of the Vlaams Instituut voor de Bevordering van het Wetenschappelijk-technologisch Onderzoek in de In-
dustrie. K. Vancompernolle and P. Vandenabeele are postdoctoral researchers of the Fonds voor Weten-
schappelijk Onderzoek–Vlaanderen.
Address correspondence to Johan Grooten, Department of Molecular Biology, Flanders Interuniversity Insti-
tute for Biotechnology and University of Gent, K.L. Ledeganckstraat 35, B-9000 Gent, Belgium. Phone:
32-9-264-53-10; Fax: 32-9-264-53-48; E-mail: johan.grooten@dmb.rug.ac.be
Received for publication 20 July 1998 and in revised form 9 September 1998.
References
1. Yang, X., H.Y. Chang, and D. Baltimore. 1998. Autopro-
teolytic activation of pro-caspases by oligomerization. Mol.
Cell. 1:319–325.
2. Srinivasula, S.M., M. Ahmad, T. Fernandes-Alnemri, G. Lit-
wack, and E.S. Alnemri. 1996. Molecular ordering of the
Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a
CrmA-inhibitable protease that activates multiple Ced-3/
Figure 3. CAF induces re-
lease of cytochrome c from iso-
lated mitochondria. Isolated
PC60 mitochondria were incu-
bated for 30 min at 378C in the
presence of control cell extract,
caspase-8–activated zVAD-fmk–
treated cell extract (CAF), or
caspase-8 (1 mg/ml) alone. The presence of cytochrome c in the super-
natant was determined by Western blot analysis.
Figure 4. Overexpression of Bcl-2 prevents CAF-induced release of
cytochrome c, but not induction of MMD. Digitonin-permeabilized Bcl-2
cells and neomycin-resistant PC60 cells were incubated for 1 h at 378C in
the presence of control cell extract (2) or caspase-8–activated zVAD-
fmk–treated cell extract (1). Cells were analyzed for release of cyto-
chrome c by Western blotting and induction of MMD by flow-cytomet-
ric determination of DCm.
ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA. 93:
14486–14491.
3. Porter, A.G., P. Ng, and R.U. Jänicke. 1997. Death sub-
strates come alive. Bioessays. 19:501–507.
4. Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and
M.E. Peter. 1998. Apoptosis signaling by death receptors.
Eur. J. Biochem. 254:439–459.2198 CAF Induces MMD and Cytochrome c Release
5. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O’Rourke,
A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R.
Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/
CED-3-like protease, is recruited to the CD95 (Fas/APO-1)
death-inducing signaling complex. Cell. 85:817–827.
6. Medema, J.P., C. Scaffidi, F.C. Kischkel, A. Shevchenko, M.
Mann, P.H. Krammer, and M.E. Peter. 1997. FLICE is acti-
vated by association with the CD95 death inducing signaling
complex (DISC). EMBO (Eur. Mol. Biol. Organ.) J. 16:2794–
2804.
7. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K.J.
Tomaselli, K.M. Debatin, P.H. Krammer, and M.E. Peter.
1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO
(Eur. Mol. Biol. Organ.) J. 17:1675–1687.
8. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang.
1996. Induction of apoptotic program in cell-free extracts:
requirement for dATP and cytochrome c. Cell. 86:147–157.
9. Zou, H., W.J. Henzel, X. Liu, A. Lutschg, and X. Wang.
1997. Apaf-1, a human protein homologous to C. elegans
CED-4, participates in cytochrome c-dependent activation of
caspase-3. Cell. 90:405–413.
10. Li, P., D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ah-
mad, E.S. Alnemri, and X. Wang. 1997. Cytochrome c and
dATP-dependent formation of Apaf-1/caspase-9 complex
initiates an apoptotic protease cascade. Cell. 91:479–489.
11. Xiang, J., D.T. Chao, and S.J. Korsemeyer. 1996. Bax-
induced cell death may not require interleukin 1b-converting
enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:14559–
14563.
12. Susin, S.A., N. Zamzami, M. Castedo, E. Daugas, M.
Geuskens, and G. Kroemer. 1997. The central executioner of
apoptosis: multiple connections between protease activation
and mitochondria in Fas/APO-1/CD95- and ceramide-
induced apoptosis. J. Exp. Med. 186:25–37.
13. Yang, J., X. Liu, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng,
D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by
Bcl-2: release of cytochrome c from mitochondria blocked.
Science. 275:1129–1132.
14. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. New-
meyer. 1997. The release of cytochrome c from mitochon-
dria: a primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136.
15. Bossy-Wetzel, E., D.D. Newmeyer, and D.R. Green. 1998.
Mitochondrial cytochrome c release in apoptosis occurs
upstream of DEVD-specific caspase activation and inde-
pendently of mitochondrial transmembrane depolarization.
EMBO (Eur. Mol. Biol. Organ.) J. 17:37–49.
16. Han, Z., G. Li, T.A. Bremner, T.S. Lange, G. Zhang, R.
Jemmerson, J.H. Wyche, and E.A. Hendrickson. 1998. A cy-
tosolic factor is required for mitochondrial cytochrome c ef-
flux during apoptosis. Cell Death Differ. 5:469–479.
17. Vandenabeele, P., W. Declercq, B. Vanhaesebroeck, J.
Grooten, and W. Fiers. 1995. Both TNF receptors are re-
quired for TNF-mediated induction of apoptosis in PC60
cells. J. Immunol. 154:2904–2913.
18. Van de Craen, M., P. Vandenabeele, W. Declercq, I. Van
den Brande, G. Van Loo, F. Molemans, P. Schotte, W. Van
Criekinge, R. Beyaert, and W. Fiers. 1997. Characterization
of seven murine caspase family members. FEBS Lett. 403:61–69.
19. Ulb, J.J., J.Y. Chatton, S. Chan, and J.W. Stucki. 1996. A
critical evaluation of in situ measurement of mitochondrial
electrical potentials in single hepatocytes. Biochim. Biophys.
Acta. 1276:124–132.
20. Marzo, I., C. Brenner, N. Zamzami, S.A. Susin, G. Beutner,
D. Brdiczka, R. Rémy, Z.H. Xie, J.C. Reed, and G. Kroe-
mer. 1998. The permeability transition pore complex: a tar-
get for apoptosis regulation by caspases and Bcl-2–related
proteins.  J. Exp. Med. 187:1261–1271.
21. Moreadith, R.W., and G. Fiskum. 1984. Isolation of mito-
chondria from ascites tumor cells permeabilized with digito-
nin. Anal. Biochem. 137:360–367.
22. Kroemer, G., N. Zamzami, and S.A. Susin. 1997. Mitochon-
drial control of apoptosis. Immunol. Today. 18:44–51.
23. Vander Heiden, M.G., N.S. Chandel, E.K. Williamson, P.T.
Schumacker, and C.B. Thompson. 1997. Bcl-xL regulates the
membrane potential and volume homeostasis of mitochon-
dria. Cell. 91:627–637.
24. Jürgensmeier, J.M., Z. Xie, Q. Deveraux, L. Ellerby, D.
Bredesen, and J.C. Reed. 1998. Bax directly induces release
of cytochrome c from isolated mitochondria. Proc. Natl. Acad.
Sci. USA. 95:4997–5002.